Ischaemia–reperfusion injury activates matrix metalloproteinases in the human heart
Open Access
- 30 November 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 26 (1), 27-35
- https://doi.org/10.1093/eurheartj/ehi007
Abstract
Aims Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) regulate matrix remodelling in the heart and play a pivotal role in myocardial dysfunction immediately following ischaemia–reperfusion injury ex vivo in rats. We investigated the changes in MMPs and TIMPs in acute myocardial ischaemia–reperfusion injury in humans. Methods and results Fifteen patients with stable angina undergoing coronary artery bypass graft surgery with cardiopulmonary bypass were enrolled. Left ventricular stroke work index was monitored prior to bypass and for 24 h following reperfusion. Left atrial biopsy samples were obtained at the start of bypass before cardioplegia and within 10 min after removal of the aortic cross-clamp. Plasma samples were collected from the radial artery and coronary sinus 1, 5, and 10 min following removal of the cross-clamp. In cardiac biopsies there was a marked increase in 72 kDa MMP-2 and 92 kDa MMP-9 activities, and a decrease in TIMP-1 upon reperfusion. Increased MMP activity correlated positively with cross-clamp duration and inversely with cardiac mechanical function 3 h following reperfusion. TIMP-1 correlated inversely with cross-clamp time and positively with cardiac mechanical function. Plasma samples revealed a significant increase in both 92 kDa MMP-9 and 64 kDa MMP-2 activities 1 min following removal of cross-clamp. Conclusion Reperfusion following cardioplegia activates MMPs in the myocardium and plasma of patients undergoing coronary artery bypass grafting. This is the first correlation of MMP myocardial activity with cardiac function in humans. The early increase in MMP activity produces a proteolytic environment that may contribute to myocardial stunning injury in humans.Keywords
This publication has 46 references indexed in Scilit:
- A Matrix Metalloproteinase Induction/Activation System Exists in the Human Left Ventricular Myocardium and Is Upregulated in Heart FailureCirculation, 2000
- Interleukin-1β and Tumor Necrosis Factor-α Decrease Collagen Synthesis and Increase Matrix Metalloproteinase Activity in Cardiac Fibroblasts In VitroCirculation Research, 2000
- Tissue inhibitors of metalloproteinases: evolution, structure and functionBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 2000
- Matrix metalloproteinase synthesis and expression in isolated LV myocyte preparationsAmerican Journal of Physiology-Heart and Circulatory Physiology, 1999
- Matrix Metalloproteinase Inhibition Attenuates Early Left Ventricular Enlargement After Experimental Myocardial Infarction in MiceCirculation, 1999
- Treating ischemic heart disease by pharmacologically improving cardiac energy metabolismThe American Journal of Cardiology, 1998
- Generation of peroxynitrite contributes to ischemia-reperfusion injury in isolated rat heartsCardiovascular Research, 1997
- Intrinsic Myofilament Alterations Underlying the Decreased Contractility of Stunned MyocardiumCirculation Research, 1996
- Induction of tissue inhibitor and matrix metalloproteinase by serum in human heart‐derived fibroblast and endomyocardial endothelial cellsJournal of Cellular Biochemistry, 1995
- Acute myocardial dysfunction and recovery: A common occurrence after coronary bypass surgeryJournal of the American College of Cardiology, 1990